Icotinib-resistant HCC827 cells produce exosomes with mRNA MET oncogenes and mediate the migration and invasion of NSCLC

Table 1 General information

SAMPLE NUMBER	GENDER	AGE	PATHOLOGICAL DIAGNOSIS	1st RECORD			TREATMENT	2nd RECORD			FOLLOW-UP PERIOD (Months)
SAMPLE NUMBER	GENDER	AGE	PATHOLOGICAL DIAGNOSIS	NEOPLASM STAGING	CEA(ug/L)	EGFR MUTATION	TREATMENT	NEOPLASM STAGING	CEA(ug/L)	EGFR MUTATION	FOLLOW-UP PERIOD (Months)
5	F	85	Adenocarcinoma	IVa	102.59	19 del	Icotinib		18.04	undetected	7
14	F	57	Adenocarcinoma	IVa	6.46	19 del	Icotinib	IVc	3.07	T790 m	4
52	F	81	Adenocarcinoma	IVa	89.24	19 del	Icotinib	IVc	77.5	undetected	6
28	M	67	Adenocarcinoma	IIIa	42.63	19 del	Icotinib		14.99	undetected	7
22	F	53	Adenocarcinoma	Iva	355.92	19 del	Icotinib	IVc	564.25	19 del	5
24	M	74	Adenocarcinoma	IVa	126.78	19 del	Icotinib		4.85	undetected	7
62	M	68	Adenocarcinoma		41.25	19 del TP53	Gefitnib		6.42	undetected	5
31	F	66	Adenocarcinoma	IVa	46.73	21L858R	Icotinib	IVc	76.11	undetected	3
39	F	79	Adenocarcinoma	IVa	1025	19 del	Gefitnib		88.1	undetected	5
4	M	86	Adenocarcinoma	IVa	10.31	21L858R	Icotinib		12.33	undetected	4

ISSN: 1465-993X